Stay updated on Rucaparib and Nivolumab in Prostate or Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the Rucaparib and Nivolumab in Prostate or Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Rucaparib and Nivolumab in Prostate or Endometrial Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T02:54:07.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    Footer updated to Revision: v3.4.2 and prior notice Revision: v3.4.1 removed; these are editorial changes that do not affect study information or site functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T14:16:43.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and open-status disclaimer; Updated the site revision to v3.4.1, replacing v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-04T10:23:46.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    - UI tweaks: add 'Show glossary' option, switch to 'Last Update Submitted that Met QC Criteria' label, and update footer to 'No FEAR Act Data' and 'Revision: v3.4.0' while removing the older 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' labels.
    Difference
    0.2%
    Check dated 2026-01-28T06:16:36.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4; no changes to the study details, eligibility criteria, or results.
    Difference
    0.1%
    Check dated 2026-01-14T03:47:57.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    Added a Locations section showing Illinois as a study site and updated to revision v3.3.3. Removed the HHS Vulnerability Disclosure and Illinois Locations entries (revision v3.3.2).
    Difference
    0.2%
    Check dated 2025-12-23T20:23:16.000Z thumbnail image

Stay in the know with updates to Rucaparib and Nivolumab in Prostate or Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Rucaparib and Nivolumab in Prostate or Endometrial Cancer Clinical Trial page.